Evidence for association of hyperprolinemia with schizophrenia and a measure of clinical outcome
about
The three-dimensional structural basis of type II hyperprolinemiaSynaptic plasticity, neural circuits, and the emerging role of altered short-term information processing in schizophrenia.Identification of a Conserved Histidine as Critical for the Catalytic Mechanism and Functional Switching of the Multifunctional Proline Utilization A Protein.Cytosolic Accumulation of L-Proline Disrupts GABA-Ergic Transmission through GAD BlockadeInborn errors of metabolism associated with psychosis: literature review and case-control study using exome data from 5090 adult individuals.Vitamin D insufficiency and schizophrenia risk: evaluation of hyperprolinemia as a mediator of association.22q11 deletion syndrome: a review of the neuropsychiatric features and their neurobiological basis.D-amino acid aberrations in cerebrospinal fluid and plasma of smokersEvidence that COMT genotype and proline interact on negative-symptom outcomes in schizophrenia and bipolar disorder.Human-specific endogenous retroviral insert serves as an enhancer for the schizophrenia-linked gene PRODH.PRODH polymorphisms, cortical volumes and thickness in schizophrenia.Safety of L-proline as a stabilizer for immunoglobulin products.Biophysical investigation of type A PutAs reveals a conserved core oligomeric structure.Structure, function, and mechanism of proline utilization A (PutA).Genome-wide association study of NMDA receptor coagonists in human cerebrospinal fluid and plasma.Discovery of the Membrane Binding Domain in Trifunctional Proline Utilization A.Proline dehydrogenase gene (PRODH) polymorphisms and schizophrenia susceptibility: a meta-analysis.Vitamin D deficiency, behavioral atypicality, anxiety and depression in children with chromosome 22q11.2 deletion syndrome.Crosstalk Among Disrupted Glutamatergic and Cholinergic Homeostasis and Inflammatory Response in Mechanisms Elicited by Proline in Astrocytes.GC-MS based metabolomics identification of possible novel biomarkers for schizophrenia in peripheral blood mononuclear cells.Deletion size analysis of 1680 22q11.2DS subjects identifies a new recombination hotspot on chromosome 22q11.2.Proline oxidase controls proline, glutamate, and glutamine cellular concentrations in a U87 glioblastoma cell line.The Proline Cycle As a Potential Cancer Therapy Target.Long-term clinical outcome, therapy and mild mitochondrial dysfunction in hyperprolinemia.Profiling of Amino Acids and Their Derivatives Biogenic Amines Before and After Antipsychotic Treatment in First-Episode Psychosis.Inactivation of the Mouse L-Proline Transporter PROT Alters Glutamatergic Synapse Biochemistry and Perturbs Behaviors Required to Respond to Environmental Changes
P2860
Q24315802-38B5CE24-D7A0-48F4-8331-6308553B284EQ26829347-08BC9C9D-7311-4D1A-B944-DD4D7DDE520AQ30101149-8E20254C-CB08-4387-910B-950A953C3DE3Q30370117-08B7DED8-367E-4510-8CBE-1CFD4BB68ABEQ31162695-CB76E29E-7663-4988-8A4D-6FEC10F88777Q33709226-EB4A1D45-3DAF-433E-B29A-54F698F773D0Q34393037-7FEB6319-AA0F-4970-90EC-13428E398D5CQ37103325-936BD894-4469-474F-BE83-3178D8223E24Q37307172-4A68DB40-5913-4D86-960F-8777490B0322Q37353019-5C78B5BE-1954-44DF-BC66-DC001ABF302FQ37548891-DE9338DF-99BF-4F2E-A103-CCA7B1C16253Q37979844-3F0CE9B7-B4A9-4091-B20F-2BCE960BD9AAQ38677885-97E0451D-959F-4B7A-BF42-1BCFE2136960Q39437714-71E6E7DE-4692-4519-89BC-6A377523C09BQ46216712-EC8B1C18-02DC-4108-B1B5-C4D1225FC92EQ47579064-1B52B7E7-3814-4E7B-9BC7-3C32D96FE1BAQ47765162-BE6D53D1-7AD2-4C91-B050-4BD60FA8D171Q48036597-2418F8D6-CF20-459F-AABC-29803DCBDAC6Q48379887-08DE74E9-A326-43DF-A3A6-BFF022CD62F2Q50635567-C3CDE8A4-7EF5-407F-AA54-0B808049390CQ52315338-2955954D-E850-4C6F-A68E-AC69F416BBE7Q52563712-2AC85AB0-2174-4DAE-AE9A-22714D9AE5EEQ52592104-300C2D45-3EF6-453A-BC4F-09F5DFC69027Q54672211-52D00AE7-981E-4DB0-940C-0E7B3F62520FQ55188589-FFE8F367-D378-4618-9820-116E6921BE82Q58451240-9ED37106-FFEB-43E1-AD1D-29250BC2DE83
P2860
Evidence for association of hyperprolinemia with schizophrenia and a measure of clinical outcome
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Evidence for association of hy ...... a measure of clinical outcome
@ast
Evidence for association of hy ...... a measure of clinical outcome
@en
type
label
Evidence for association of hy ...... a measure of clinical outcome
@ast
Evidence for association of hy ...... a measure of clinical outcome
@en
prefLabel
Evidence for association of hy ...... a measure of clinical outcome
@ast
Evidence for association of hy ...... a measure of clinical outcome
@en
P2093
P2860
P1476
Evidence for association of hy ...... a measure of clinical outcome
@en
P2093
Amanda N Baraldi
Carrie A Pappas
Catherine L Clelland
Corinne P Bart
James D Clelland
Laura J Panek
Laura L Read
Robert H Nadrich
P2860
P304
P356
10.1016/J.SCHRES.2011.05.006
P407
P577
2011-06-08T00:00:00Z